Inventor · disambiguated record
Anna N. Moraitis
Also filed as: MORAITIS ANNA · MORAITIS ANNA N
6 granted patents·4 pending applications·17 citations·filing 2008–2019
79Inventor score
Files withADC THERAPEUTICS SA4ALETHIA BIOTHERAPEUTICS INC3TREMBLAY GILLES BERNARD2DAIICHI SANKYO CO LTD1
Top patents by PatentIndex Score
10 records- 0185US9393302B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·20 claims
- 0285US8937163B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofTREMBLAY GILLES BERNARD·Filed 2012·Granted Jan 20, 2015·6 cites·20 claims
- 0384US9828426B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 0476US9493562B2Anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 15, 2016·3 cites·14 claims
- 0574US2021054067A1Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 0662US11084872B2Method for treating breast cancerADC THERAPEUTICS SA·Filed 2018·Granted Aug 10, 2021·0 cites·23 claims
- 0762US10597450B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2017·Granted Mar 24, 2020·0 cites·70 claims
- 0852US2011286924A1Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancerTREMBLAY GILLES BERNARD·Filed 2008·Application pending·0 cites
- 0949US2017174753A1Method for treating breast cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1034US2017129956A1Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfectaDAIICHI SANKYO CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna N. Moraitis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →